Literature DB >> 3510139

Calcitonin inhibition of insulin release from isolated rat pancreatic islets.

A Alwmark, M W Stavinoha, C W Cooper, G H Greeley, J C Thompson.   

Abstract

Calcitonin is known to inhibit secretion of gastrin and insulin in vivo. The objective of this study was to determine whether calcitonin can act directly on pancreatic islets in vitro to inhibit insulin release. Isolated islets were obtained from collagenase-treated rat pancreas, and three peptides (gastrin-releasing peptide, cholecystokinin-8, bombesin) and glucose were used to stimulate insulin release. All agents caused a significant increase in insulin secretion and calcitonin inhibited these responses, but had no consistent effect on basal release. This study provides evidence that calcitonin is an effective inhibitor of insulin secretion and acts directly on islet tissue.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3510139     DOI: 10.2337/diab.35.1.58

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  2 in total

1.  Effect of (8-32) salmon calcitonin, an amylin antagonist, on insulin, glucagon and somatostatin release: study in the perfused pancreas of the rat.

Authors:  R A Silvestre; M Salas; J Rodríguez-Gallardo; O García-Hermida; T Fontela; J Marco
Journal:  Br J Pharmacol       Date:  1996-01       Impact factor: 8.739

2.  Calcitonin, as SMS 201-995, ameliorates the VIPoma syndrome.

Authors:  A Antonelli; C Gambuzza; F Bertoni; L Baschieri
Journal:  J Endocrinol Invest       Date:  1993-01       Impact factor: 4.256

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.